Lisa Sartz (Former)
1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
NT-rådets ställningstagande till eculizumab är oacceptabelt
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Slutreplik, Diana Karpman och medförfattare : - NT-rådet bör omedelbart återkalla sitt beslut om eculizumab
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Eculizumab treatment for rescue of renal function in IgA nephropathy.
(
- Contribution to journal › Article
- 2012
-
Mark
A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome.
(
- Contribution to journal › Article
- 2011
-
Mark
Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis
(
- Contribution to journal › Article
-
Mark
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2010
-
Mark
Clinical, epidemiological and molecular aspects of hemolytic uremic syndrome
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Complement Activation on Platelet-Leukocyte Complexes and Microparticles in Enterohemorrhagic Escherichia coli-Induced Hemolytic Uremic Syndrome
(
- Contribution to journal › Published meeting abstract
-
Mark
Pathophysiology of typical hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2009
-
Mark
Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
(
- Contribution to journal › Article